Beta-carotene, vitamin C, and vitamin e and cardiovascular diseases

被引:39
作者
Dagenais G.R. [1 ]
Marchioli R. [2 ]
Tognoni G. [3 ]
Yusuf S. [4 ]
机构
[1] Institut de Cardiologie de Québec, Hôpital Laval, Ste-Foy, Québec, G1V 4G5
[2] Consorzio Mario Negri Sud, Santa-Maria Imbaro
[3] Mario Negri Institute, Milano
[4] Hamilton General Hospital, McMaster University, Hamilton, ON
关键词
Ischemic Heart Disease; Carotene; Peripheral Artery Disease; Intermittent Claudication; Male Smoker;
D O I
10.1007/s11886-000-0084-4
中图分类号
学科分类号
摘要
Observational studies have shown an inverse relationship between consumption of fruits and vegetables high in beta-carotene, vitamins C and E, and ischemic heart disease (IHD) and stroke. In large observational studies, betacarotene reduced the risk of IHD events in men, particularly in smokers. In contrast, four large randomized trials did not reveal a reduction in cardiovascular events with beta-carotene use, and may, in fact, increase IHD and total mortality in male smokers. There have been only a few large observational studies and one randomized trial with vitamin C, which have shown no beneficial or deleterious impact of this vitamin on cardiovascular events. Most large observational studies have shown an inverse relationship between vitamin E and IHD. However, a meta-analysis of the four randomized trials done in Europe and America involving a total of 51,000 participants allocated to vitamin E or placebo for 1.4 to 6 years, did not demonstrate a reduction in cardiovascular and IHD mortality and nonfatal myocardial infarction. Currently, there are no data to support the use of these vitamins to reduce the risk of cardiovascular events. Trials are in progress to determine whether a longer duration of administration of vitamin E or the association of vitamin E with cofactors may reduce cardiovascular events. Copyright © 2000 by Current Science Inc.
引用
收藏
页码:293 / 299
页数:6
相关论文
共 44 条
[1]  
Hennekens C.H., Gaziano J.M., Manson J.E., Buring J.E., Antioxidant vitamin-cardiovascular disease hypothesis is still promising, but still unproven: The need for randomized trials, Am J Clin Nutr, 62, SUPPL. 6, (1995)
[2]  
Diaz M.N., Frei B., Vita J.A., Keaney Jr. J.F., Antioxidants and atherosclerotic heart disease, N Engl J Med, 337, pp. 408-416, (1997)
[3]  
Lonn E.M., Yusuf S., Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data, Can J Cardiol, 13, pp. 957-965, (1997)
[4]  
Hercberg S., Galan P., Preziosi P., Et al., The potential role of antioxidant vitamins in preventing cardiovascular diseases and cancers, Nutrition, 14, pp. 513-520, (1998)
[5]  
Tribble D.L., Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and betacarotene. A statement for health care professionals from the American Heart Association, Circulation, 99, pp. 591-595, (1999)
[6]  
Steinberg D., Parthasarathy S., Carew T.E., Et al., Beyond cholesterol. Modification of low-density lipoprotein that increases its atherogenicity, N Eng J Med, 320, pp. 915-924, (1989)
[7]  
Carew T.E., Schwenke D.C., Steinberg D., Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit, Proc Natl Acad Sci U S A, 84, pp. 7725-7729, (1987)
[8]  
Verlangieri A.J., Bush M.J., Effects of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis, J Am Coll Nutr, 11, pp. 131-138, (1992)
[9]  
Jilial I., Norkus E.P., Cristol L., Grundy S.M., B-carotene inhibits the oxidative modification of low density lipoprotein, Biochim Biophys Acta, 1086, pp. 134-138, (1991)
[10]  
Tsuchihashi H., Kigoshi M., Iwatsuki M., Niki E., Action of b-carotene as an antioxidant against lipid peroxidation, Arch Biochem Biophys, 323, pp. 137-147, (1995)